AMRI’s diverse offering of screening programs and collections give customers the essential tools to efficiently and safely identify active compounds during the lead finding phases of drug discovery and development.
AMRI’s screening collections are comprised of synthetic and natural products that can be used in conjunction with assay development and screening services to enable lead finding.
Key features of AMRI’s screening programs and collections include:
- Availability of high throughput, absolute potency, and selectivity screening services
- Support of both large scale screens of client or AMRI sample collections
- Extensive performance testing
- AMRI tests tens of thousands of samples per day for activity
- Customers have cost effective access to AMRI’s collection of over 150,000 discrete compounds